ARTICLE | Company News
Celebrex approved for ankylosing spondylitis
July 29, 2005 11:35 PM UTC
FDA approved an sNDA for Celebrex celecoxib from Pfizer (PFE) to relieve the signs and symptoms of ankylosing spondylitis. The COX-2 inhibitor is approved in the U.S. to treat osteoarthritis, rheumato...